| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:Kri 1314
CAS:128053-53-2
Purity:0 Package:100mg/RMB 29500;25mg/RMB 17200;50mg/RMB 22800
|
|
| | Cyclohexanebutanoicacid, a-hydroxy-b-[[(2S)-3-(1H-imidazol-5-yl)-2-[[(2R)-4-(4-morpholinyl)-2-(1-naphthalenylmethyl)-1,4-dioxobutyl]amino]-1-oxopropyl]amino]-,1-methylethyl ester, (aR,bS)- Basic information |
| Product Name: | Cyclohexanebutanoicacid, a-hydroxy-b-[[(2S)-3-(1H-imidazol-5-yl)-2-[[(2R)-4-(4-morpholinyl)-2-(1-naphthalenylmethyl)-1,4-dioxobutyl]amino]-1-oxopropyl]amino]-,1-methylethyl ester, (aR,bS)- | | Synonyms: | Cyclohexanebutanoicacid, a-hydroxy-b-[[(2S)-3-(1H-imidazol-5-yl)-2-[[(2R)-4-(4-morpholinyl)-2-(1-naphthalenylmethyl)-1,4-dioxobutyl]amino]-1-oxopropyl]amino]-,1-methylethyl ester, (aR,bS)-;Cyclohexanebutanoic acid, α-hydroxy-β-[[(2S)-3-(1H-imidazol-5-yl)-2-[[(2R)-4-(4-morpholinyl)-2-(1-naphthalenylmethyl)-1,4-dioxobutyl]amino]-1-oxopropyl]amino]-, 1-methylethyl ester, (αR,βS)- | | CAS: | 128053-53-2 | | MF: | C38H51N5O7 | | MW: | 689.85 | | EINECS: | | | Product Categories: | | | Mol File: | 128053-53-2.mol | ![Cyclohexanebutanoicacid, a-hydroxy-b-[[(2S)-3-(1H-imidazol-5-yl)-2-[[(2R)-4-(4-morpholinyl)-2-(1-naphthalenylmethyl)-1,4-dioxobutyl]amino]-1-oxopropyl]amino]-,1-methylethyl ester, (aR,bS)- Structure](CAS/20211123/GIF/128053-53-2.gif) |
| | Cyclohexanebutanoicacid, a-hydroxy-b-[[(2S)-3-(1H-imidazol-5-yl)-2-[[(2R)-4-(4-morpholinyl)-2-(1-naphthalenylmethyl)-1,4-dioxobutyl]amino]-1-oxopropyl]amino]-,1-methylethyl ester, (aR,bS)- Chemical Properties |
| Melting point | 99-104 °C | | Boiling point | 1005.1±65.0 °C(Predicted) | | density | 1.234±0.06 g/cm3(Predicted) | | pka | 12.45±0.20(Predicted) |
| | Cyclohexanebutanoicacid, a-hydroxy-b-[[(2S)-3-(1H-imidazol-5-yl)-2-[[(2R)-4-(4-morpholinyl)-2-(1-naphthalenylmethyl)-1,4-dioxobutyl]amino]-1-oxopropyl]amino]-,1-methylethyl ester, (aR,bS)- Usage And Synthesis |
| Description | Kri 1314 is a cyclohexyl-norstatine-containing dipeptide renin inhibitor which has potential for the treatment of hypertension. |
| | Cyclohexanebutanoicacid, a-hydroxy-b-[[(2S)-3-(1H-imidazol-5-yl)-2-[[(2R)-4-(4-morpholinyl)-2-(1-naphthalenylmethyl)-1,4-dioxobutyl]amino]-1-oxopropyl]amino]-,1-methylethyl ester, (aR,bS)- Preparation Products And Raw materials |
|